Products Platforms Companies News Contact

Vendor source

Reviewed 11 May 2026

Completeness Strong (64%)

JPC-01K

JPC-01K is an AI medical system that detects the area of prostate cancer using multiparametric MR images. The system is based on artificial neural networks to analyze the MR images of the prostate cancer patients. The system uses multiparametric MR images, T2, DWI, and DCE, as input and visualizes the location of the prostate cancer and their probability.

No papers to support — we monitor for new evidence.

Key Features

Prostate cancer detection

General Information

Product name

JPC-01K

Company

JLK Inc.

Modality

Main task

Not specified

Subspeciality

Abdomen

Disease targeted

Prostate cancer

Regulatory Information

CE Certification

Pathway:

MDD

Class:

Class I

Verified by Health AI Register

Other certifications

Not specified

Evidence & Research

No research papers or evidence on file yet.

The registry monitors publications for new evidence.

Technical Specifications

Patient population age

Not specified

Input

multi sequence MR images (T2, DWI(Diffusion Weighted Image), DCE(Dynamic Contrast Enhanced))

Input format

DICOM, JPG

Output

Heatmap overlay, the probability of prostate cancer

Output format

Report, UI

Integration

Stand-alone third party application, Stand-alone webbased

Deployment

Cloud-based, Hybrid solution, Locally on dedicated hardware

Trigger for analysis

On demand, triggered by a user through e.g. a button click, image upload

Processing time

10 - 60 seconds

Population

all prostate MR

Market Presence

On market since

04-2019

AI Platforms

Resellers

Not specified

Countries present

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Subscription

Based on

Number of installations, Number of users

Source: Vendor | First published: Jul 1, 2020 | Last updated: May 11, 2026